Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (91-100 of 1,279) with videos related to

Pageof 128
Sort By:
Alimentary Pharmacology & Therapeutics|December 19, 2019
Editorial: rapid disease progression in hepatitis delta-can we turn the tide? Authors' replyAdriana Palom, Mar Riveiro-Barciela, Maria Buti, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2007
Evaluating the cost of sustained virologic response in naïve chronic hepatitis C patients treated à la carteM Buti, M A Casado, R Esteban
European Journal of Oral Implantology|March 5, 2015
Efficacy of surgical and non-surgical interventions on accelerating orthodontic tooth movement: a systematic reviewZamira Kalemaj, Cesare Lorenzo DebernardI, Jacopo Buti
Acta Bio-Medica : Atenei Parmensis|June 6, 2014
A wide skull ostelytic metastasis in advanced breast cancerSebastiano Buti, Anselmo Alessandro Palumbo, Angelica Sikokis
Alimentary Pharmacology & Therapeutics|August 8, 2022
Editorial: pegylated interferon combined with bulevirtide for chronic hepatitis delta-new life for an old timer?Mar Riveiro-Barciela, Adriana Palom, Maria Buti
Journal of Hepatology|August 25, 2015
Management of direct-acting antiviral agent failuresMaria Buti, Mar Riveiro-Barciela, Rafael Esteban
Revista Espanola De Enfermedades Digestivas|August 31, 2022
New actors come into play against hepatitis deltaMar Riveiro-Barciela, Adriana Palom, Maria Buti
Journal of Viral Hepatitis|January 12, 2012
Severe anaemia related to oseltamivir during treatment of chronic hepatitis C: a new drug interaction?M Simón-Talero, M Buti, R Esteban
Enfermedades Infecciosas Y Microbiologia Clinica|March 6, 2012
[Hepatitis E: molecular virology, epidemiology and pathogenesis]Francisco Rodríguez-Frias, Rosendo Jardi, María Buti
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
Long-term safety and efficacy of nucleo(t)side analogue therapy in hepatitis BMaria Buti, Mar Riveiro-Barciela, Rafael Esteban
Pageof 128

Showing results (91-100 of 1,279) with videos related to

Sort By:
Pageof 128
Alimentary Pharmacology & Therapeutics|December 19, 2019
Editorial: rapid disease progression in hepatitis delta-can we turn the tide? Authors' replyAdriana Palom, Mar Riveiro-Barciela, Maria Buti, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2007
Evaluating the cost of sustained virologic response in naïve chronic hepatitis C patients treated à la carteM Buti, M A Casado, R Esteban
European Journal of Oral Implantology|March 5, 2015
Efficacy of surgical and non-surgical interventions on accelerating orthodontic tooth movement: a systematic reviewZamira Kalemaj, Cesare Lorenzo DebernardI, Jacopo Buti
Acta Bio-Medica : Atenei Parmensis|June 6, 2014
A wide skull ostelytic metastasis in advanced breast cancerSebastiano Buti, Anselmo Alessandro Palumbo, Angelica Sikokis
Alimentary Pharmacology & Therapeutics|August 8, 2022
Editorial: pegylated interferon combined with bulevirtide for chronic hepatitis delta-new life for an old timer?Mar Riveiro-Barciela, Adriana Palom, Maria Buti
Journal of Hepatology|August 25, 2015
Management of direct-acting antiviral agent failuresMaria Buti, Mar Riveiro-Barciela, Rafael Esteban
Revista Espanola De Enfermedades Digestivas|August 31, 2022
New actors come into play against hepatitis deltaMar Riveiro-Barciela, Adriana Palom, Maria Buti
Journal of Viral Hepatitis|January 12, 2012
Severe anaemia related to oseltamivir during treatment of chronic hepatitis C: a new drug interaction?M Simón-Talero, M Buti, R Esteban
Enfermedades Infecciosas Y Microbiologia Clinica|March 6, 2012
[Hepatitis E: molecular virology, epidemiology and pathogenesis]Francisco Rodríguez-Frias, Rosendo Jardi, María Buti
Liver International : Official Journal of the International Association for the Study of the Liver|February 11, 2018
Long-term safety and efficacy of nucleo(t)side analogue therapy in hepatitis BMaria Buti, Mar Riveiro-Barciela, Rafael Esteban
Pageof 128